Photo from wikipedia
To identify biomarkers that predict the response to standard androgen deprivation therapy (ADT) of patients newly diagnosed with metastatic castration‐sensitive prostate cancer (CSPC) in order to improve therapeutic decision‐making, and… Click to show full abstract
To identify biomarkers that predict the response to standard androgen deprivation therapy (ADT) of patients newly diagnosed with metastatic castration‐sensitive prostate cancer (CSPC) in order to improve therapeutic decision‐making, and to investigate whether the characterization of baseline circulating tumour cells (CTCs) would predict the effective period of standard ADT.
Keywords:
castration sensitive;
prostate cancer;
metastatic castration;
circulating tumour;
castration;
sensitive prostate
Journal Title: BJU International
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: BJU International
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!